Screener
Pediatrix Medical Group MD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 11.3%— | 10.9%— | —— | —— | —— | |
| Net margin | 9%— | 8.6%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 20.9%— | 20.3%— | —— | —— | —— | |
| Return on invested capital | 12.6%— | 13.7%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 0.9×-0.1× | 0.9×0.0× | 0.9×0.0× | 0.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.5× | 1.7×+0.2× | 1.8×+0.4× | 1.8×+0.4× | 1.8×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×-0.1× | 0.7×-0.1× | 0.7×+0.6× | 0.8×+0.7× | 0.8×+0.7× | |
| Net debt / EBITDA | 1.8×— | 1.1×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $10.58+14.5% | $10.14+10.4% | $10.40+20.0% | $9.75+15.0% | $9.24-10.2% | |
| Valuation | ||||||
| Market capitalization | $2.16B+54.9% | $1.84B+63.0% | $1.46B+51.0% | $1.16B+82.6% | $1.24B+49.6% | |
| Price / earnings | 12.4×— | 11.1×— | —— | —— | —— | |
| Price / sales | 1.1×+0.4× | 1×+0.4× | 0.8×+0.3× | 0.6×+0.3× | 0.6×+0.2× | |
| Price / book | 2.5×+0.9× | 2.1×+0.6× | 1.6×+0.3× | 1.4×+0.5× | 1.6×+0.6× | |
| EV / EBITDA | 10.7×— | 9.1×— | —— | —— | —— |
FAQ
- Where do Pediatrix Medical Group's ratios come from?
- Every ratio is computed from Pediatrix Medical Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
